Motivational properties of opioids: evidence that an activation of σ-receptors mediates reinforcement processes
Abstract
The role of central delta-opioid receptors in the mediation of opioid reinforcement and endogenous reward processes was examined using a non-biased place-preference conditioning procedure. Intracerebroventricular (i.c.v.) administration of the selective delta-receptor agonist, [D-Pen2, D-Pen5]-enkephalin (DPDPE, 10.0-25.0 micrograms) produced a significant preference for the drug-associated place and a similar effect was observed following i.c.v. injections of morphine (10.0 micrograms). Administration of the delta-receptor antagonist, ICI 174,864, at doses (1.0-5.0 micrograms, i.c.v.) which had no aversive effects when tested alone, abolished the reinforcing properties of DPDPE. Such treatment did not, however, modify the effect of morphine. These findings demonstrate the involvement delta- as well as mu-receptors in the motivational properties of opioids and suggest that the activation of either receptor type is sufficient for the elicitation of appetitively reinforcing effects.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Based on animal studies, the role of opioids in the positive reinforcing effects of natural rewards and drugs of abuse has largely been attributed to MOR in the nucleus accumbens, ventral pallidum, and VTA, though some part is also played by DOR.
“Based on animal studies, the role of opioids in the positive reinforcing effects of natural rewards and drugs of abuse has largely been attributed to MOR in the NAC, VP, and VTA, though some part is also played by DOR (van Ree and de Wied 1980; Shippenberg et al 1987; Hubner and Koob 1990; Olmstead and Franklin 1997a; Corrigall et al 2000; Pecina and Berridge 2000; Van Ree et al 2000; Gerrits et”
From The behavioral, anatomical and pharmacological parallels between social attachment, love and addiction (2012) · cites this paper as Shippenberg et al 1987
MOR and DOR mediate generally positive motivation and affect, while KOR mediates generally negative motivation and aversion.
“Nonetheless, the three receptor types have different behavioral domains, with MOR and DOR mediating generally positive motivation and affect, while KOR mediates generally negative motivation and aversion (Pfeiffer et al 1986; Shippenberg et al 1987; Pecina and Berridge 2000; McLaughlin et al 2003; for reviews see Van Ree et al 2000; Le Merrer et al 2009).”
From The behavioral, anatomical and pharmacological parallels between social attachment, love and addiction (2012) · cites this paper as Shippenberg et al 1987
Cites
The rat brain in stereotaxic coordinates
Palkovits, M. (1983) · Neuropeptides · doi:10.1016/0143-4179(83)90049-5 · Cited by 28,959 · see citing works
The Rat Brain in Stereotaxic Coordinates
Paxinos, G., & Watson, C. (1983) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 28,585 · see citing works
Feinleib, M., & Zar, J. H. (1975) · Journal of the American Statistical Association · doi:10.2307/2285423 · Cited by 12,671 · see citing works
Endogenous opioid peptides: multiple agonists and receptors
Lord, J. A. H., Waterfield, A. A., Hughes, J., & Kosterlitz, H. W. (1977) · Nature · doi:10.1038/267495a0 · Cited by 2,485 · see citing works
Multiple opiate receptors. Enkephalins and morphine bind to receptors of different specificity.
Chang, K. J., & Cuatrecasas, P. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)30115-1 · Cited by 683 · see citing works
Mucha, R. F., & Herz, A. (1985) · Psychopharmacology · doi:10.1007/bf00432213 · Cited by 515 · see citing works
Self-citationThe binding spectrum of narcotic analgesic drugs with different agonist and antagonist properties
Magnan, J., Paterson, S. J., Tavani, A., & Kosterlitz, H. W. (1982) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00495865 · Cited by 509 · see citing works
Mucha, R. F., & Iversen, S. D. (1984) · Psychopharmacology · doi:10.1007/bf00427782 · Cited by 311 · see citing works
Self-administration of methionine enkephalin into the nucleus accumbens
Goeders, N. E., Lane, J. D., & Smith, J. E. (1984) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(84)90284-3 · Cited by 245 · see citing works
Experimental methods for the study of state-dependent learning.
Overton, D. A. (1974) · PubMed · Cited by 243 · see citing works
Reinforcing effects of brain microinjections of morphine revealed by conditioned place preference
van der Kooy, D., Mucha, R. F., O'Shaughnessy, M., & Bucenieks, P. (1982) · Brain Research · doi:10.1016/0006-8993(82)91124-6 · Cited by 240 · see citing works
Aversive conditioning by psychoactive drugs: Effects of morphine, alcohol and chlordiazepoxide
Cappell, H., LeBlanc, A. E., & Endrényi, L. (1973) · Psychopharmacology · doi:10.1007/bf00414038 · Cited by 210 · see citing works
Jasinski, D. R., Martin, W. R., & Sapira, J. D. (1968) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt196892215 · Cited by 117 · see citing works
The use of [3H]‐[ d ‐Pen2, d ‐Pen5]enkephalin as a highly selective ligand for the δ‐binding site
Cotton, R., Kosterlitz, H. W., Paterson, S. J., Rance, M. J., & Traynor, J. R. (1985) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1985.tb17387.x · Cited by 101 · see citing works
Reward produced by microinjection of (d-Ala2),Met5-enkephalinamide into the ventral tegmental area
Phillips, A. G., & LePiane, F. G. (1982) · Behavioural Brain Research · doi:10.1016/0166-4328(82)90057-2 · Cited by 100 · see citing works
Self-administration of D-Ala2-Met-enkephalinamide at hypothalamic self-stimulation sites
OLDS, M. E., & Williams, K. (1980) · Brain Research · doi:10.1016/0006-8993(80)91325-6 · Cited by 73 · see citing works
Studies in vivo with ICI 174864 and []enkephalin
Cowan, A., Zhu, X. Z., & Porreca, F. (1985) · Neuropeptides · doi:10.1016/0143-4179(85)90015-0 · Cited by 51 · see citing works
The μ, κ and δ properties of various opioid agonists
Takemori, A. E., Ikeda, M., & Portoghese, P. S. (1986) · European Journal of Pharmacology · doi:10.1016/0014-2999(86)90709-0 · Cited by 49 · see citing works
Motivational effects of opioids: Evidence on the role of endorphins in mediating reward or aversion
Stolerman, I. P. (1985) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(85)90086-3 · Cited by 38 · see citing works
Hirning, L. D., Mosberg, H. I., Hurst, R., Hruby, V. J., Burks, T. F., & Porreca, F. (1985) · Neuropeptides · doi:10.1016/0143-4179(85)90034-4 · Cited by 31 · see citing works
Pharmacology of δ-opioid receptor in the hamster vas deferens
Sheehan, M. J., Hayes, A. G., & Tyers, M. B. (1986) · European Journal of Pharmacology · doi:10.1016/0014-2999(86)90183-4 · Cited by 25 · see citing works
Motivational properties of opioids.
Shippenberg, T. S., & Herz, A. (1989) · PubMed · Cited by 14 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Matthes, H. W. D., Maldonado, R., Simonin, F., Valverde, O., Slowe, S., Kitchen, I., Befort, K., Dierich, A., Le Meur, M., Dollé, P., et al. (1996) · Nature · doi:10.1038/383819a0 · Cited by 1,722 · see citing works
Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications
Mansour, A., Fox, C. A., Akil, H., & Watson, S. J. (1995) · Trends in Neurosciences · doi:10.1016/0166-2236(95)93946-u · Cited by 1,297 · see citing works
Tzschentke, T. (1998) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00060-4 · Cited by 1,254 · see citing works
Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway.
Spanagel, R., Herz, A., & Shippenberg, T. S. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.6.2046 · Cited by 1,005 · see citing works
Self-citationMu, delta, and kappa opioid receptor mRNA expression in the rat CNS: An in situ hybridization study
Mansour, A., Fox, C. A., Burke, S., Meng, F., Thompson, R. C., Akil, H., & Watson, S. J. (1994) · The Journal of Comparative Neurology · doi:10.1002/cne.903500307 · Cited by 872 · see citing works
Spanagel, R., Herz, A., & Shippenberg, T. S. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb04963.x · Cited by 539 · see citing works
Self-citationSimonin, F., Valverde, O., Smadja, C., Slowe, S., Kitchen, I., Dierich, A., Le Meur, M., Roques, B. P., Maldonado, R., & Kieffer, B. L. (1998) · The EMBO Journal · doi:10.1093/emboj/17.4.886 · Cited by 418 · see citing works
Mello, N. K. (1996) · Neuropsychopharmacology · doi:10.1016/0893-133x(95)00274-h · Cited by 390 · see citing works
Burkett, J. P., & Young, L. J. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2794-x · Cited by 307 · see citing works
“Activation of MOR in the VTA and DOR in the NAC is directly rewarding in rats , producing conditioned place preferences ( Goeders et al .”
InfluentialOpioids, Reward and Addiction: An Encounter of Biology, Psychology, and Medicine
van Ree, J. M., Gerrits, M. A. F. M., & Vanderschuren, L. J. M. J. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01405-4 · Cited by 300 · see citing works
Self-administration of morphine, DAMGO, and DPDPE into the ventral tegmental area of rats
Devine, D. P., & Wise, R. (1994) · Journal of Neuroscience · doi:10.1523/jneurosci.14-04-01978.1994 · Cited by 256 · see citing works
Trends in place preference conditioning with a cross-indexed bibliography; 1957–1991
Schechter, M., & Calcagnetti, D. J. (1993) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(05)80228-3 · Cited by 230 · see citing works
Evidence that the aversive effects of opioid antagonists and ?-agonists are centrally mediated
Bals-Kubik, R., Herz, A., & Shippenberg, T. S. (1989) · Psychopharmacology · doi:10.1007/bf00444692 · Cited by 199 · see citing works
Self-citationThe use of place conditioning in studying the neuropharmacology of drug reinforcement
Huffman, D. C. (1989) · Brain Research Bulletin · doi:10.1016/0361-9230(89)90224-4 · Cited by 192 · see citing works
Jutras‐Aswad, D., DiNieri, J. A., Harkany, T., & Hurd, Y. L. (2009) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-009-0027-z · Cited by 184 · see citing works
Bolaños, C. A., Garmsen, G. M., Clair, M. A., & McDougall, S. A. (1996) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00698-x · Cited by 157 · see citing works
Absence of Δ-9-Tetrahydrocannabinol Dysphoric Effects in Dynorphin-Deficient Mice
Zimmer, A., Valjent, E., König, M., Zimmer, A. M., Robledo, P., Hahn, H., Valverde, O., & Maldonado, R. J. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-23-09499.2001 · Cited by 140 · see citing works
Negus, S. S., Gatch, M. B., Mello, N. K., Zhang, X., & Rice, K. C. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37596-2 · Cited by 142 · see citing works
Merrer, J. L., Plaza‐Zabala, A., Boca, C. D., Matifas, A., Maldonado, R. J., & Kieffer, B. L. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.10.021 · Cited by 128 · see citing works
Longoni, R., Spina, L., Mulas, A., Carboni, E., Garau, L., Melchiorri, P., & Chiara, G. D. (1991) · Journal of Neuroscience · doi:10.1523/jneurosci.11-06-01565.1991 · Cited by 126 · see citing works
Kuzmin, A. V., Semenova, S., Gerrits, M. A. F. M., Zvartau, E. E., & van Ree, J. M. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00961-2 · Cited by 122 · see citing works
μ- and κ-opioid receptor-meiated opioid effects on social play in juvenile rats
Vanderschuren, L. J. M. J., Niesink, R. J. M., Spruijt, B. M., & van Ree, J. M. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00040-r · Cited by 118 · see citing works
Molecular mechanisms of maternal cannabis and cigarette use on human neurodevelopment
Morris, C. V., DiNieri, J. A., Szutorisz, H., & Hurd, Y. L. (2011) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2011.07884.x · Cited by 111 · see citing works
Spanagel, R., Almeida, O. F. X., Bartl, C., & Shippenberg, T. S. (1994) · Psychopharmacology · doi:10.1007/bf02244761 · Cited by 110 · see citing works
Self-citationBals-Kubik, R., Shippenberg, T. S., & Herz, A. (1990) · European Journal of Pharmacology · doi:10.1016/0014-2999(90)90153-w · Cited by 109 · see citing works
Self-citationNeuropharmacology of the Naturally Occurring κ-Opioid Hallucinogen Salvinorin A
Cunningham, C. W., Rothman, R. B., & Prisinzano, T. E. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.003244 · Cited by 111 · see citing works
Targeting dynorphin/kappa opioid receptor systems to treat alcohol abuse and dependence
Walker, B. M., Valdez, G. R., McLaughlin, J. P., & Bakalkin, G. Y. (2012) · Alcohol · doi:10.1016/j.alcohol.2011.10.006 · Cited by 104 · see citing works
Tejedor‐Real, P., Micó, J. A., Smadja, C., Maldonado, R. J., Roques, B. P., & Gibert‐Rahola, J. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00423-3 · Cited by 99 · see citing works
Chefer, V. I., & Shippenberg, T. S. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.128 · Cited by 97 · see citing works
Self-citationMorphine-induced place preference in the CXBK mouse: characteristics of μ opioid receptor subtypes
Suzuki, T., Funada, M., Narita, M., Misawa, M., & Nagase, H. (1993) · Brain Research · doi:10.1016/0006-8993(93)90239-j · Cited by 92 · see citing works
Conditioning of Opioid Reinforcement: Neuroanatomical and Neurochemical Substrates
Shippenberg, T. S., Herz, A., Spanagel, R., Bals-Kubik, R., & Stein, C. (1992) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1992.tb25980.x · Cited by 91 · see citing works
Self-citationWang, H., & Pickel, V. M. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-09-03242.2001 · Cited by 90 · see citing works
Naloxone fails to produce conditioned place aversion in μ-opioid receptor knock-out mice
Skoubis, P. D., Matthes, H. W. D., Walwyn, W. M., Kieffer, B. L., & Maidment, N. T. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00333-5 · Cited by 86 · see citing works
Matsuzawa, S., Suzuki, T., Misawa, M., & Nagase, H. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00008-4 · Cited by 83 · see citing works
Lenard, N. R., Daniels, D. J., Portoghese, P. S., & Roerig, S. C. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.02.040 · Cited by 82 · see citing works
Endogenous enkephalins, not endorphins, modulate basal hedonic state in mice
Skoubis, P. D., Lam, H. A., Shoblock, J. R., Narayanan, S., & Maidment, N. T. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.03956.x · Cited by 82 · see citing works
Strain differences in the rewarding and dopamine-releasing effects of morphine in rats
Shoaib, M., Spanagel, R., Stöhr, T., & Shippenberg, T. S. (1995) · Psychopharmacology · doi:10.1007/bf02245193 · Cited by 79 · see citing works
Self-citationReceptor Subtypes in Opioid and Stimulant Reward
Self, D. W., & Stein, L. (1992) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1992.tb00435.x · Cited by 79 · see citing works
Elmer, G. I., Pieper, J. O., Goldberg, S. R., & George, F. R. (1995) · Psychopharmacology · doi:10.1007/bf02245094 · Cited by 77 · see citing works
Sequential Analysis of Juvenile Isolation-Induced Decreased Social Behavior in the Adult Rat
den Berg, C. L. V., van Ree, J. M., & Spruijt, B. M. (1999) · Physiology & Behavior · doi:10.1016/s0031-9384(99)00062-1 · Cited by 75 · see citing works
Neuroanatomical substrates mediating the aversive effects of D-1 dopamine receptor antagonists
Shippenberg, T. S., Bals-Kubik, R., Huber, A., & Herz, A. (1991) · Psychopharmacology · doi:10.1007/bf02244205 · Cited by 74 · see citing works
Self-citationInteraction between Endogenous Opioids and Dopamine within the Nucleus Accumbensa
Stinus, L., Cador, M., & Moal, M. L. (1992) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1992.tb25972.x · Cited by 72 · see citing works
Shippenberg, T. S., Stein, C., Huber, A., Millan, M. J., & Herz, A. (1988) · Pain · doi:10.1016/0304-3959(88)90225-4 · Cited by 71 · see citing works
Self-citationSvingos, A. L., Clarke, C. L., & Pickel, V. M. (1999) · Synapse · doi:10.1002/(sici)1098-2396(199910)34:1 · Cited by 67 · see citing works
Svingos, A. L., Clarke, C. L., & Pickel, V. M. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-05-01923.1998 · Cited by 64 · see citing works
Alcohol-induced plasticity in the dynorphin/kappa-opioid receptor system
SIROHI, S. K., Bakalkin, G. Y., & Walker, B. M. (2012) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2012.00095 · Cited by 64 · see citing works
Drug interactions in the reinforcing effects of over-the-counter cough syrups
Suzuki, T., Masukawa, Y., & Misawa, M. (1990) · Psychopharmacology · doi:10.1007/bf02247122 · Cited by 64 · see citing works
Pertussis toxin abolishes μ- and δ-opioid agonist-induced place perference
Suzuki, T., Funada, M., Narita, M., Miwa, M., & Nagase, H. (1991) · European Journal of Pharmacology · doi:10.1016/0014-2999(91)90774-k · Cited by 63 · see citing works
Dykstra, L. A., Preston, K. L., & Bigelow, G. E. (1997) · Psychopharmacology · doi:10.1007/s002130050208 · Cited by 60 · see citing works
Targeting Endogenous Mu- and Delta-Opioid Receptor Systems for the Treatment of Drug Addiction
Shippenberg, T. S., LeFevour, A., & Chefer, V. I. (2008) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152708786927813 · Cited by 58 · see citing works
Self-citationSkoubis, P. D., & Maidment, N. T. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00121-0 · Cited by 54 · see citing works
Carmo, G. P. D., Folk, J. E., Rice, K. C., Chartoff, E. H., Carlezon, W. A., & Negus, S. S. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.12.021 · Cited by 55 · see citing works
Pitchers, K. K., Coppens, C. M., Beloate, L. N., Fuller, J., Văn, S. N., Frohmader, K. S., Laviolette, S. R., Lehman, M. N., & Coolen, L. M. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.0133-14.2014 · Cited by 55 · see citing works
Pharmacology of Sucrose-Reinforced Place-Preference Conditioning
Delamater, A. R., Sclafani, A. J., & Bodnar, R. J. (2000) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(99)00251-8 · Cited by 55 · see citing works
Lack of dependence and rewarding effects of deltorphin II in mu-opioid receptor-deficient mice
Hutcheson, D. M., Matthes, H. W. D., Valjent, E., Sánchez‐Blázquez, P., Rodríguez‐Díaz, M., Garzón, J., Kieffer, B. L., & Maldonado, R. J. (2001) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2001.01363.x · Cited by 54 · see citing works
The role of δ-opioid receptor subtypes in cocaine- and methamphetamine-induced place preferences
Suzuki, T., Mori, T., Tsuji, M., Misawa, M., & Nagase, H. (1994) · Life Sciences · doi:10.1016/0024-3205(94)00774-8 · Cited by 52 · see citing works
Wood, M. D., Daniel, A. M., & Papini, M. R. (2005) · Behavioral Neuroscience · doi:10.1037/0735-7044.119.2.446 · Cited by 52 · see citing works
David, V., Matifas, A., Gavello-Baudy, S., Decorte, L., Kieffer, B. L., & Cazala, P. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301529 · Cited by 50 · see citing works
Olson, G. A., Olson, R. D., & Kastin, A. J. (1989) · Peptides · doi:10.1016/0196-9781(89)90098-3 · Cited by 50 · see citing works
Blockade of δ-Opioid Receptors Prevents Morphine-Induced Place Preference in Mice
Suzuki, T., Yoshiike, M., Mizoguchi, H., Kamei, J., Misawa, M., & Nagase, H. (1994) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.66.131 · Cited by 49 · see citing works
Involvement of Opioid μ1 Receptors in Morphine-Induced Conditioned Place Preference In Rats
Piepponen, P. T. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(96)00567-9 · Cited by 49 · see citing works
Antidepressant‐like effects of CCKBantagonists in mice: antagonism by naltrindole
Derrien, M., Durieux, C., & Roques, B. P. (1994) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1994.tb14832.x · Cited by 49 · see citing works
Akil, H., Meng, F., Devine, D. P., & Watson, S. J. (1997) · Seminars in Neuroscience · doi:10.1006/smns.1997.0108 · Cited by 48 · see citing works
Lack of involvement ofδ-opioid receptors in mediating the rewarding effects of cocaine
Vries, T. J. D., Babovic‐Vuksanovic, D., Elmer, G. I., & Shippenberg, T. S. (1995) · Psychopharmacology · doi:10.1007/bf02245816 · Cited by 46 · see citing works
Self-citationSvingos, A. L., Cheng, P. Y., Clarke, C. L., & Pickel, V. M. (1995) · Brain Research · doi:10.1016/0006-8993(95)00977-x · Cited by 47 · see citing works
Disruption of endogenous opioid activity during instrumental learning enhances habit acquisition
Wassum, K. M., Cely, I. C., Maidment, N. T., & Balleine, B. W. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.06.071 · Cited by 46 · see citing works
Genotypic differences in mesolimbic enkephalin gene expression in DBA/2J and C57BL/6J inbred mice
Ng, G., O’Dowd, B. F., & George, S. R. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(96)00401-3 · Cited by 45 · see citing works
Suzuki, T., Tsuji, M., Mori, T., Ikeda, H., Misawa, M., & Nagase, H. (1997) · Brain Research · doi:10.1016/s0006-8993(96)01119-5 · Cited by 43 · see citing works
?-Endorphin-(1-27) is a naturally occurring antagonist of the reinforcing effects of opioids
Bals-Kubik, R., Herz, A., & Shippenberg, T. S. (1988) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00172115 · Cited by 42 · see citing works
Self-citationHippocampal μ-receptors mediate opioid reinforcement in the CA3 region
Stevens, K. E., Shiotsu, G., & Stein, L. (1991) · Brain Research · doi:10.1016/0006-8993(91)91263-z · Cited by 40 · see citing works
Salvia divinorum use and phenomenology: results from an online survey
Sumnall, H. R., Measham, F. C., Brandt, S. D., & Cole, J. C. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881110385596 · Cited by 37 · see citing works
Neurochemical Aspects of Addiction: Opioids and Other Drugs of Abuse
Herz, A., & Shippenberg, T. S. (1989) · Springer eBooks · doi:10.1007/978-1-4613-8817-3_4 · Cited by 38 · see citing works
Self-citationLong‐term cognitive enrichment affects opioid receptor expression in the amygdala of domestic pigs
Kalbe, C., & Puppe, B. (2009) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2009.00536.x · Cited by 36 · see citing works
Matsuzawa, S., Suzuki, T., Misawa, M., & Nagase, H. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00679-9 · Cited by 36 · see citing works
Morphine-6-glucuronide contributes to rewarding effects of opiates
Abbott, F. V., & Franklin, K. B. J. (1991) · Life Sciences · doi:10.1016/0024-3205(91)90453-i · Cited by 36 · see citing works
Sorge, R. E., & Stewart, J. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0485-1 · Cited by 34 · see citing works
WARD, S., & Roberts, D. C. S. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.05.003 · Cited by 34 · see citing works
HZ2, a Selective Kappa‐Opioid Agonist
Kögel, B. Y., Christoph, T., Friderichs, E., Hennies, H. ‐., Matthiesen, T., Schneider, J., & Holzgrabe, U. (1998) · CNS Drug Reviews · doi:10.1111/j.1527-3458.1998.tb00041.x · Cited by 34 · see citing works
Noble, F., Fournié‐Zaluski, M., & Roques, B. P. (1993) · European Journal of Pharmacology · doi:10.1016/0014-2999(93)90796-k · Cited by 34 · see citing works
Merrer, J. L., Faget, L. C., Matifas, A., & Kieffer, B. L. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2693-1 · Cited by 33 · see citing works
Co-localization of GABA with other neuroactive substances in the basal ganglia
McGinty, J. F. (2007) · Progress in brain research · doi:10.1016/s0079-6123(06)60016-2 · Cited by 33 · see citing works
Watson, S. J., Trujillo, K. A., Herman, J. P., & Akil, H. (1989) · Springer eBooks · doi:10.1007/978-1-4613-8817-3_2 · Cited by 33 · see citing works
Opioidergic contribution to conditioned place preference induced by corn oil in mice
Imaizumi, M., Takeda, M., Sawano, S., & Fushiki, T. (2001) · Behavioural Brain Research · doi:10.1016/s0166-4328(00)00388-0 · Cited by 31 · see citing works
Shippenberg, T., Millan, M., Mucha, R., & Herz, A. (1988) · European Journal of Pharmacology · doi:10.1016/0014-2999(88)90090-8 · Cited by 30 · see citing works
Self-citationFailure to discriminate conspecifics in amygdaloid-lesioned mice
Borlongan, C. V., & Watanabe, S. (1994) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(94)90331-x · Cited by 31 · see citing works
Daug�, V., Rossignol, P., & Roques, B. P. (1989) · Psychopharmacology · doi:10.1007/bf00442803 · Cited by 31 · see citing works
Leriche, M., Cote-Vélez, A., & Méndez, M. (2007) · Neuropeptides · doi:10.1016/j.npep.2007.08.004 · Cited by 30 · see citing works
RB101‐mediated Protection of Endogenous Opioids: Potential Therapeutic Utility?
Jutkiewicz, E. M. (2007) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2007.00011.x · Cited by 30 · see citing works
Shaikh, M. B., Shaikh, A. B., & Siegel, A. (1988) · Peptides · doi:10.1016/0196-9781(88)90080-0 · Cited by 30 · see citing works
Femenía, T., & Manzanares, J. (2011) · Addiction Biology · doi:10.1111/j.1369-1600.2011.00378.x · Cited by 29 · see citing works
Shoblock, J. R., & Maidment, N. T. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.05.011 · Cited by 29 · see citing works
Delta Opioid Receptors: Learning and Motivation
Pellissier, L. P., Pujol, C., Becker, J. A. J., & Merrer, J. L. (2016) · Handbook of experimental pharmacology · doi:10.1007/164_2016_89 · Cited by 30 · see citing works
Carr, K. D. (1990) · Brain Research · doi:10.1016/0006-8993(90)90106-l · Cited by 29 · see citing works
Involvement of δ- and μ-opioid receptors in the potentiation of brain-stimulation reward
Duvauchelle, C. L., Fleming, S. M., & Kornetsky, C. H. (1996) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00674-7 · Cited by 29 · see citing works
Liang, J., Li, Y., Ping, X., Yu, P., Zuo, Y., Wu, L., Han, J., & Cui, C. (2006) · Peptides · doi:10.1016/j.peptides.2006.08.011 · Cited by 28 · see citing works
Martin, T. J., Kim, S. A., Cannon, D. G., Sizemore, G. M., Bian, D., Porreca, F., & Smith, J. E. (2000) · PubMed · Cited by 28 · see citing works
Speciale, S. G., Manaye, K. F., Sadeq, M., & German, D. C. (1993) · Journal of Neural Transmission · doi:10.1007/bf01244918 · Cited by 27 · see citing works
Suzuki, T., Tsuji, M., Mori, T., Misawa, M., & Nagase, H. (1996) · Psychopharmacology · doi:10.1007/bf02246659 · Cited by 26 · see citing works
Shippenberg, T. S., Emmett‐Oglesby, M. W., & Herz, A. (1989) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(89)90221-9 · Cited by 26 · see citing works
Self-citationBeloate, L. N., & Coolen, L. M. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.10.024 · Cited by 25 · see citing works
- Authors
- Shippenberg, T. S., Bals-Kubik, R., & Herz, A.
- Affiliations
- Max Planck Institute of Psychiatry (DE)
- Corresponding author
- Shippenberg, T.S.
- Venue
- Brain Research
- Publisher
- Elsevier BV
- Published
- 1987-12
- Volume
- 436
- Issue
- 2
- Pages
- 234-239
- ISSN
- 0006-8993 (ISSN-L)
- OpenAlex
- W2084913220
- Cited by
- 166
- References
- 22
- Citations by year
- 2025: 1 · 2018: 1 · 2017: 4 · 2016: 1 · 2015: 1 · 2014: 1 · 2013: 4 · 2012: 5
- FWCI
- 2.51
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Brain Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pharmacological Receptor Mechanisms and Effects
- Keywords
- delta opioid receptor, opioid reinforcement, place preference, morphine, DPDPE, ICI 174,864, mu-opioid receptor, intracerebroventricular administration
- MeSH terms
- Animals, Appetitive Behavior, Avoidance Learning, Enkephalin, Leucine, Enkephalins, Injections, Intraventricular, Male, Morphine, Motivation, Rats, Inbred Strains, Receptors, Opioid, Reinforcement, Psychology, Receptors, Opioid, delta, Enkephalin, D-Penicillamine (2,5)-, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review